EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Major cardiovascular events in long-term multiple myeloma survivors: a Korean case–control study (the CAREMM-2105 study)

Jeonghoon Ha, Suein Choi, Seulji Moon, Jinseon Han, Jeongyoon Lee, Ki-Hyun Baek, Seunghoon Han, Sung-Soo Park, Chang-Ki Min

Clinical and Experimental Medicine · 2024

DOI: 10.1007/s10238-024-01368-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Medicine, 2024. Verfasst von Jeonghoon Ha und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of…. Hauptthemen laut MEDLINE: Multiple Myeloma, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Despite improvements in multiple myeloma (MM) survival rates, data on cardiovascular outcomes in long-term survivors remain lacking.

Methods

This retrospective case–control study utilized the Korean National Health Insurance Service database (2009–2020) to compare the incidence of cardiovascular disease (CVD) between patients with MM and a matched control group, focusing on long-term (> 5 years) survivors. A preliminary case cohort (n = 15,402 patients with MM) and a matched control cohort (n = 123,216 patients without MM) were established based on birth year and sex. Following 1:1 propensity score matching, the final matched cohorts each comprised 15,402 participants.

Results

The case and control cohorts were comparable in mean age (66.2 ± 11.5 years vs. 66.1 ± 11.3 years), sex, age distribution, and comorbidities. By the 8-year follow-up, the cumulative incidence of CV events (12.5% vs. 22.1%) and CVD risk were significantly lower in the case cohort. The 5-year landmark analysis revealed significant differences in CVD incidence between the cohorts (7.8% [case cohort] vs. 9.8% [control cohort]), with variations across age groups and sex, highlighting a significantly higher CVD risk among patients aged < 50 years in the case cohort ( P < 0.001).

Conclusions

These findings underscore the need for vigilant CVD monitoring in MM long-term survivors, particularly those aged < 50 years at first diagnosis. Implication for Cancer Survivors This study highlights the importance of integrating cardiovascular monitoring and risk management into long-term care for MM survivors, with a focus on younger patients and personalized interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaCardiovascular DiseasesHumansMaleFemaleAgedMiddle AgedRepublic of KoreaCase-Control StudiesRetrospective StudiesIncidenceCancer SurvivorsAged, 80 and overRisk FactorsAdult

Stichwörter der Autor:innen

Cardiovascular diseaseMortalityMultiple myelomaSurvivors

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Pharmacometrics Institute for Practical Education and Training (PIPET), College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea. waystolove@catholic.ac.kr.
  • Pharmacometrics Institute for Practical Education and Training (PIPET), College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea. waystolove@catholic.ac.kr.

Zitieren

APA

Ha, J., Choi, S., Moon, S., Han, J., Lee, J., Baek, K. H., Han, S., Park, S. S., & Min, C. K. (2024). Major cardiovascular events in long-term multiple myeloma survivors: a Korean case–control study (the CAREMM-2105 study). Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-024-01368-2

Vancouver

Ha J, Choi S, Moon S, Han J, Lee J, Baek KH, et al. Major cardiovascular events in long-term multiple myeloma survivors: a Korean case–control study (the CAREMM-2105 study). Clinical and Experimental Medicine. 2024. doi:10.1007/s10238-024-01368-2

BibTeX
@article{Ha2024,
  author = {Ha, Jeonghoon and Choi, Suein and Moon, Seulji and Han, Jinseon and Lee, Jeongyoon and Baek, Ki-Hyun and Han, Seunghoon and Park, Sung-Soo and Min, Chang-Ki},
  title = {Major cardiovascular events in long-term multiple myeloma survivors: a Korean case–control study (the CAREMM-2105 study)},
  journal = {Clinical and Experimental Medicine},
  year = {2024},
  doi = {10.1007/s10238-024-01368-2}
}
Kostenlos starten →